Lawrence Mark H
Known title: Chief Financial OfficerCIK: 0001701170
Associated companies
Transaction History
| NUS | ▲ Buy | Option Exercise | 18,041 | $549K | 3/2/2023 | View on chart |
| NUS | ▼ Sell | Open Market | 26,144 | $1.1M | 3/2/2023 | View on chart |
| NUS | ▲ Buy | Grant | 19,899 | $0 | 2/22/2023 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 2,868 | $130K | 2/15/2023 | View on chart |
| NUS | ▼ Sell | Open Market | 5,868 | $276K | 6/6/2022 | View on chart |
| NUS | ▲ Buy | Grant | 11,381 | $0 | 2/25/2022 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 5,139 | $255K | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nu Skin: Turnaround Narrative Gains Attention
A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.
Nu Skin: Turnaround Narrative Gains Attention. A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.